表紙
市場調查報告書

CountryFocus:英國的醫療、規定、醫療費給付制度情勢

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - UK

出版商 GlobalData 商品編碼 284115
出版日期 內容資訊 英文 169 Pages
訂單完成後即時交付
價格
Back to Top
CountryFocus:英國的醫療、規定、醫療費給付制度情勢 CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - UK
出版日期: 2018年12月01日內容資訊: 英文 169 Pages
簡介

英國的醫藥品市場在2012年達到240億美元規模,預計2020年增加到317億美元,將以年複合成長率3.5%成長。

本報告提供英國的醫療、規定、醫療費給付制度調查分析、醫藥品及醫療設備市場概要、醫療費給付制度與其相關資訊、法規當局結構和法規概要、該國情況、醫療基礎設施等的最新資訊,也包含市場機會與課題,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 醫藥品、醫療設備市場概要

  • 醫藥品市場
  • 醫療設備市場
  • 推動市場要素、障礙

第4章 市場進入

  • 醫療費給付、保險費支付者情勢
  • 法規情況

第5章 該國分析

  • 政策環境
  • 經濟情況
  • 經濟指標
  • 人口統計
  • 醫療基礎設施
  • 醫療費
  • 產業團體
  • 展覽會

第6章 機會與課題

  • 機會
  • 課題

第7章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC0053CHR

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - UK". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the UK. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the UK. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

The value of the UK pharmaceutical market increased from £13.2bn ($20.3bn) in 2010 to £19.6bn ($25.9bn) in 2017, at a compound annual growth rate (CAGR) of 5.9% in the terms of GBP and 3.5% in the terms of US$. The market is expected to reach £26.2bn ($30.9bn) in 2022. The increased usage of personalized medicines, incorporating digital technology into drug development and accelerating drug access pathway, high disease burden and rise in elderly population are the main driving factors of pharmaceutical market. In 2015, the medical device market in the UK was worth $17.8 billion, which increased to $19.1 billion in 2017 at a CAGR of 3.6%. It is expected to grow at a CAGR of 4.1% from $19.8 billion in 2018 to $26.3 billion in 2025. The main segments were in vitro diagnostics, ophthalmic devices, cardiovascular devices, wound care devices and orthopedic devices. The development in personalized or precision medicines, incorporation of genetic sequencing and personal genome data, is revolutionizing the approach medical practitioners and pharmaceutical industries are undertaking for the disease treatment.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the UK, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (AstraZeneca, GlaxoSmithKline, Merck, Novartis and Pfizer) and profiles and SWOT analyses of the major players in the medical device market (Siemens, Roche, DePuy, Essilor and Smith & Nephew)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of the UK
  • Porter's five forces analysis for pharmaceutical and medical devices market of the UK
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the UK healthcare market.

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

  • Develop business strategies by understanding the trends shaping and driving the UK healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in the UK healthcare market.

Table of Contents

  • Executive Summary
  • Overview of Pharmaceutical Market
  • Overview of Medical Device Market
  • Deals Analysis
  • Porter's Five Forces Model
  • Market Access
  • Country Healthcare Landscape
  • Opportunities and Challenges

Appendix

Back to Top